

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.89628677 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.89628677 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 6.72061709 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.66584714 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.66584714 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.04081555 |
| 7 | regulation of fibrinolysis (GO:0051917) | 5.97982627 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.92277276 |
| 9 | behavioral response to nicotine (GO:0035095) | 5.66705782 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46626313 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.38445304 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.24396405 |
| 13 | protein carboxylation (GO:0018214) | 5.24396405 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.15569061 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.08625371 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.01108868 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 5.01108868 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 5.01108868 |
| 19 | negative regulation of cholesterol transport (GO:0032375) | 4.94397809 |
| 20 | negative regulation of sterol transport (GO:0032372) | 4.94397809 |
| 21 | urea cycle (GO:0000050) | 4.91560297 |
| 22 | urea metabolic process (GO:0019627) | 4.91560297 |
| 23 | regulation of immunoglobulin secretion (GO:0051023) | 4.79472682 |
| 24 | reverse cholesterol transport (GO:0043691) | 4.74197688 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.74093921 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.69918807 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.58604460 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.51745682 |
| 29 | bile acid metabolic process (GO:0008206) | 4.49291634 |
| 30 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.45064621 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.44323870 |
| 32 | protein-lipid complex remodeling (GO:0034368) | 4.41662263 |
| 33 | macromolecular complex remodeling (GO:0034367) | 4.41662263 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 4.41662263 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 4.40796987 |
| 36 | triglyceride homeostasis (GO:0070328) | 4.38890739 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.38890739 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.36447191 |
| 39 | regulation of chronic inflammatory response (GO:0002676) | 4.33410122 |
| 40 | cysteine metabolic process (GO:0006534) | 4.32978283 |
| 41 | phospholipid efflux (GO:0033700) | 4.32899936 |
| 42 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.32657301 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 4.32327190 |
| 44 | serine family amino acid catabolic process (GO:0009071) | 4.29670349 |
| 45 | complement activation, alternative pathway (GO:0006957) | 4.28313511 |
| 46 | regulation of plasminogen activation (GO:0010755) | 4.27591420 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 4.24187790 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 4.23079117 |
| 49 | fibrinolysis (GO:0042730) | 4.22659857 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.18762401 |
| 51 | DNA deamination (GO:0045006) | 4.18696805 |
| 52 | regulation of complement activation (GO:0030449) | 4.15063504 |
| 53 | lysine catabolic process (GO:0006554) | 4.12559474 |
| 54 | lysine metabolic process (GO:0006553) | 4.12559474 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 4.11307892 |
| 56 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.03951150 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.00200672 |
| 58 | cholesterol efflux (GO:0033344) | 3.99804623 |
| 59 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.97984938 |
| 60 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.97984938 |
| 61 | NADH dehydrogenase complex assembly (GO:0010257) | 3.97984938 |
| 62 | alpha-amino acid catabolic process (GO:1901606) | 3.96316605 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 3.95447394 |
| 64 | endoderm formation (GO:0001706) | 3.92670628 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.91666760 |
| 66 | bile acid and bile salt transport (GO:0015721) | 3.89536715 |
| 67 | homocysteine metabolic process (GO:0050667) | 3.83668528 |
| 68 | cellular glucuronidation (GO:0052695) | 3.81343574 |
| 69 | glutamate metabolic process (GO:0006536) | 3.76872237 |
| 70 | glycine metabolic process (GO:0006544) | 3.75919277 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 3.74516338 |
| 72 | coenzyme catabolic process (GO:0009109) | 3.71508411 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70377361 |
| 74 | protein complex biogenesis (GO:0070271) | 3.66242695 |
| 75 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.66012419 |
| 76 | positive regulation of defense response to virus by host (GO:0002230) | 3.65971330 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.63146244 |
| 78 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.61604459 |
| 79 | negative regulation of lipase activity (GO:0060192) | 3.61245439 |
| 80 | protein-lipid complex assembly (GO:0065005) | 3.60409278 |
| 81 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59271532 |
| 82 | positive regulation of lipid catabolic process (GO:0050996) | 3.57878318 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 3.57212264 |
| 84 | drug catabolic process (GO:0042737) | 3.55501997 |
| 85 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.54180892 |
| 86 | sulfation (GO:0051923) | 3.52841248 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.52699814 |
| 88 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.50958801 |
| 89 | positive regulation of glomerulus development (GO:0090193) | 3.47683147 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.47339934 |
| 91 | arginine metabolic process (GO:0006525) | 3.47296528 |
| 92 | serine family amino acid metabolic process (GO:0009069) | 3.47239109 |
| 93 | lipoprotein metabolic process (GO:0042157) | 3.46320366 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46182659 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.45850136 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 3.45374480 |
| 97 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.42764377 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.41990703 |
| 99 | intestinal cholesterol absorption (GO:0030299) | 3.41595489 |
| 100 | phospholipid homeostasis (GO:0055091) | 3.39828790 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.39435051 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.39435051 |
| 103 | sterol homeostasis (GO:0055092) | 3.39200451 |
| 104 | interferon-gamma production (GO:0032609) | 3.38856869 |
| 105 | ketone body metabolic process (GO:1902224) | 3.36774022 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.32176850 |
| 107 | regulation of glomerulus development (GO:0090192) | 3.31634306 |
| 108 | response to lipoprotein particle (GO:0055094) | 3.30991159 |
| 109 | aldehyde catabolic process (GO:0046185) | 3.29289440 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.28873546 |
| 111 | glucuronate metabolic process (GO:0019585) | 3.28873546 |
| 112 | cellular biogenic amine catabolic process (GO:0042402) | 3.27981838 |
| 113 | amine catabolic process (GO:0009310) | 3.27981838 |
| 114 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.27536313 |
| 115 | protein-lipid complex subunit organization (GO:0071825) | 3.26717233 |
| 116 | positive regulation of hemostasis (GO:1900048) | 3.26516928 |
| 117 | positive regulation of blood coagulation (GO:0030194) | 3.26516928 |
| 118 | acute-phase response (GO:0006953) | 3.25484392 |
| 119 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.24380014 |
| 120 | interferon-gamma secretion (GO:0072643) | 3.22860090 |
| 121 | cellular response to ATP (GO:0071318) | 3.22563977 |
| 122 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.22281501 |
| 123 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.22104838 |
| 124 | negative regulation of lipid transport (GO:0032369) | 3.21901192 |
| 125 | blood coagulation, intrinsic pathway (GO:0007597) | 3.21196768 |
| 126 | drug metabolic process (GO:0017144) | 3.20632304 |
| 127 | synaptic transmission, cholinergic (GO:0007271) | 3.17892064 |
| 128 | dentate gyrus development (GO:0021542) | 3.17836354 |
| 129 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.16549686 |
| 130 | cellular response to nicotine (GO:0071316) | 3.13231289 |
| 131 | somite development (GO:0061053) | 3.09470392 |
| 132 | regulation of vitamin metabolic process (GO:0030656) | 3.07189384 |
| 133 | negative regulation of telomerase activity (GO:0051974) | 3.06541274 |
| 134 | positive regulation of isotype switching (GO:0045830) | 3.03026001 |
| 135 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.02578348 |
| 136 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.98555342 |
| 137 | positive regulation of heat generation (GO:0031652) | 2.98544024 |
| 138 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.93396297 |
| 139 | platelet dense granule organization (GO:0060155) | 2.93264905 |
| 140 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.88439963 |
| 141 | positive regulation of interleukin-17 production (GO:0032740) | 2.86265426 |
| 142 | positive regulation of DNA recombination (GO:0045911) | 2.84302667 |
| 143 | regulation of germinal center formation (GO:0002634) | 2.84105663 |
| 144 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.82840705 |
| 145 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.81286541 |
| 146 | eosinophil chemotaxis (GO:0048245) | 2.80473144 |
| 147 | regulation of fever generation (GO:0031620) | 2.72372271 |
| 148 | negative regulation of interleukin-10 production (GO:0032693) | 2.71245679 |
| 149 | cell proliferation in forebrain (GO:0021846) | 2.70940252 |
| 150 | activation of MAPKKK activity (GO:0000185) | 2.68103808 |
| 151 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.67459949 |
| 152 | negative regulation of amino acid transport (GO:0051956) | 2.66495564 |
| 153 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.65575695 |
| 154 | negative regulation of acute inflammatory response (GO:0002674) | 2.62153968 |
| 155 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.61031430 |
| 156 | positive regulation of prostaglandin secretion (GO:0032308) | 2.59764177 |
| 157 | germinal center formation (GO:0002467) | 2.58191924 |
| 158 | regulation of telomerase activity (GO:0051972) | 2.54429231 |
| 159 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.53633309 |
| 160 | prostate gland growth (GO:0060736) | 2.53448497 |
| 161 | positive regulation of immunoglobulin production (GO:0002639) | 2.53223211 |
| 162 | cellular response to exogenous dsRNA (GO:0071360) | 2.53031549 |
| 163 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.52255344 |
| 164 | positive regulation of fatty acid transport (GO:2000193) | 2.50444163 |
| 165 | tolerance induction (GO:0002507) | 2.50347294 |
| 166 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.48062252 |
| 167 | protein polyglutamylation (GO:0018095) | 2.48001214 |
| 168 | positive regulation of B cell mediated immunity (GO:0002714) | 2.47952760 |
| 169 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.47952760 |
| 170 | positive regulation of activated T cell proliferation (GO:0042104) | 2.47559564 |
| 171 | peristalsis (GO:0030432) | 2.45608888 |
| 172 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.45421550 |
| 173 | eosinophil migration (GO:0072677) | 2.44887741 |
| 174 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.42392346 |
| 175 | negative regulation of lipid storage (GO:0010888) | 2.41564074 |
| 176 | regulation of heat generation (GO:0031650) | 2.39317157 |
| 177 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.36517137 |
| 178 | myeloid dendritic cell differentiation (GO:0043011) | 2.36002709 |
| 179 | positive regulation of B cell proliferation (GO:0030890) | 2.35885899 |
| 180 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.35613375 |
| 181 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.34307547 |
| 182 | negative regulation of T cell differentiation (GO:0045581) | 2.33698890 |
| 183 | positive regulation of T cell apoptotic process (GO:0070234) | 2.32823667 |
| 184 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.32497803 |
| 185 | ATP synthesis coupled proton transport (GO:0015986) | 2.31845171 |
| 186 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.31845171 |
| 187 | regulation of T-helper cell differentiation (GO:0045622) | 2.31463143 |
| 188 | T cell lineage commitment (GO:0002360) | 2.31229679 |
| 189 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.30387892 |
| 190 | regulation of defense response to virus by host (GO:0050691) | 2.29413005 |
| 191 | positive regulation of metanephros development (GO:0072216) | 2.29322191 |
| 192 | negative regulation of mast cell activation (GO:0033004) | 2.29255932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.52485010 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.44282551 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.82868200 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.23365848 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.19366194 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.57283424 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.18923709 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.14725241 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79122454 |
| 10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.53571089 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.06965547 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.99097565 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.63995143 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.50799288 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.48960906 |
| 16 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.47839622 |
| 17 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.46365104 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.42485220 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.36746924 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.34187159 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33014209 |
| 22 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.22834183 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21011748 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.19353201 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.16939702 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10381369 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09251281 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.03287505 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2624097 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99267088 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98407419 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.96864035 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95601210 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95522988 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.90803080 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.90298704 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.88728951 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84809992 |
| 39 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.81026510 |
| 40 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.80266301 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.78607616 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.78037192 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77306146 |
| 44 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.77163586 |
| 45 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77061303 |
| 46 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76953516 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.75143140 |
| 48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.74543814 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.74530132 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.73923728 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.69946949 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69815373 |
| 53 | EWS_26573619_Chip-Seq_HEK293_Human | 1.67654199 |
| 54 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.66673651 |
| 55 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.66673651 |
| 56 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66539616 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.65167101 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62902229 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58990142 |
| 60 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.58966496 |
| 61 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55422998 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54739835 |
| 63 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54688758 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53117706 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52681365 |
| 66 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52001945 |
| 67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50144230 |
| 68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.43040823 |
| 69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.42810586 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42161740 |
| 71 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.39286212 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38682585 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37773457 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34947048 |
| 75 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.32024298 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27509081 |
| 77 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.27221315 |
| 78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.24818681 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23933762 |
| 80 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.22686960 |
| 81 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22347709 |
| 82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22347709 |
| 83 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21746586 |
| 84 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21396652 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20616430 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.18374010 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17558586 |
| 88 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17319514 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17061415 |
| 90 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15223408 |
| 91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13866562 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11860806 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10733230 |
| 94 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10688201 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10009639 |
| 96 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09859501 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09803651 |
| 98 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09231701 |
| 99 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07802334 |
| 100 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06132480 |
| 101 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04857753 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04441776 |
| 103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02400289 |
| 104 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.00105375 |
| 105 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.99647824 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98291347 |
| 107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97124740 |
| 108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96941362 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96879917 |
| 110 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94550539 |
| 111 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94148596 |
| 112 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93827390 |
| 113 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93453543 |
| 114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91688324 |
| 115 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91440049 |
| 116 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91368375 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91363301 |
| 118 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91017715 |
| 119 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.90468802 |
| 120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90288428 |
| 121 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89323413 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89321755 |
| 123 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89321755 |
| 124 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.89108080 |
| 125 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.89017163 |
| 126 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88674335 |
| 127 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88674335 |
| 128 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87202247 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87170039 |
| 130 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.86432131 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86293217 |
| 132 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.85886942 |
| 133 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.85744331 |
| 134 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.85727836 |
| 135 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85719882 |
| 136 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85525372 |
| 137 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85328053 |
| 138 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84704034 |
| 139 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84086081 |
| 140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83474302 |
| 141 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83363270 |
| 142 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81401624 |
| 143 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81259751 |
| 144 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81259751 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80894873 |
| 146 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78183702 |
| 147 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76356219 |
| 148 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.75846565 |
| 149 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75519432 |
| 150 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74720889 |
| 151 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74562865 |
| 152 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73731729 |
| 153 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73430282 |
| 154 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.73380802 |
| 155 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71344932 |
| 156 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.71254826 |
| 157 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69876902 |
| 158 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.68476143 |
| 159 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.68476143 |
| 160 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.68365251 |
| 161 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68207976 |
| 162 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66017595 |
| 163 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.64115972 |
| 164 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.64115972 |
| 165 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63621784 |
| 166 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.61993393 |
| 167 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61951956 |
| 168 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61251925 |
| 169 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61105891 |
| 170 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60521964 |
| 171 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60361045 |
| 172 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.59178266 |
| 173 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.59056871 |
| 174 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.58770849 |
| 175 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58238046 |
| 176 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58040099 |
| 177 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.57923724 |
| 178 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.57595973 |
| 179 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.56455141 |
| 180 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.56406915 |
| 181 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.56197239 |
| 182 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.56141235 |
| 183 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55510451 |
| 184 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.55269162 |
| 185 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.54893488 |
| 186 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.54396989 |
| 187 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.54151750 |
| 188 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.53968994 |
| 189 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.53635857 |
| 190 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.53532991 |
| 191 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53106854 |
| 192 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53094782 |
| 193 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.52665709 |
| 194 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.52446407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.69394747 |
| 2 | MP0005360_urolithiasis | 6.76209457 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.55701109 |
| 4 | MP0005365_abnormal_bile_salt | 5.50971592 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.65520596 |
| 6 | MP0003252_abnormal_bile_duct | 3.60322083 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.43127229 |
| 8 | MP0005671_abnormal_response_to | 3.38970896 |
| 9 | MP0009840_abnormal_foam_cell | 3.28953811 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.12063991 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.88050763 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.83850383 |
| 13 | MP0005083_abnormal_biliary_tract | 2.78938820 |
| 14 | MP0003195_calcinosis | 2.72251814 |
| 15 | MP0003724_increased_susceptibility_to | 2.47206807 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.42737757 |
| 17 | MP0005332_abnormal_amino_acid | 2.29386831 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.23250612 |
| 19 | MP0003880_abnormal_central_pattern | 2.21646048 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.21229696 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.18821720 |
| 22 | MP0001790_abnormal_immune_system | 2.17377670 |
| 23 | MP0005387_immune_system_phenotype | 2.17377670 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.16254145 |
| 25 | MP0000609_abnormal_liver_physiology | 2.14761895 |
| 26 | MP0002638_abnormal_pupillary_reflex | 2.11771509 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 2.08311208 |
| 28 | MP0005646_abnormal_pituitary_gland | 2.07112287 |
| 29 | MP0002163_abnormal_gland_morphology | 2.03596805 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.99539384 |
| 31 | MP0003646_muscle_fatigue | 1.95016945 |
| 32 | MP0003868_abnormal_feces_composition | 1.94608124 |
| 33 | MP0004742_abnormal_vestibular_system | 1.93112952 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.86985238 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.82487959 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.80409663 |
| 37 | MP0009785_altered_susceptibility_to | 1.79030182 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.76487337 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.75289817 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.69151069 |
| 41 | MP0001800_abnormal_humoral_immune | 1.67206050 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.65254395 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.62312508 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.62085937 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.61291340 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.60745266 |
| 47 | MP0004142_abnormal_muscle_tone | 1.57925537 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.54825224 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.53869991 |
| 50 | MP0005389_reproductive_system_phenotype | 1.50590446 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.47937841 |
| 52 | MP0002160_abnormal_reproductive_system | 1.47165388 |
| 53 | MP0000516_abnormal_urinary_system | 1.45041053 |
| 54 | MP0005367_renal/urinary_system_phenotyp | 1.45041053 |
| 55 | MP0000604_amyloidosis | 1.43777734 |
| 56 | MP0002272_abnormal_nervous_system | 1.40709673 |
| 57 | MP0005253_abnormal_eye_physiology | 1.40607406 |
| 58 | MP0004510_myositis | 1.36771709 |
| 59 | MP0003787_abnormal_imprinting | 1.36693122 |
| 60 | MP0001919_abnormal_reproductive_system | 1.36633244 |
| 61 | MP0004133_heterotaxia | 1.35549393 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.35443462 |
| 63 | MP0002723_abnormal_immune_serum | 1.34161360 |
| 64 | MP0002735_abnormal_chemical_nociception | 1.34005113 |
| 65 | MP0002751_abnormal_autonomic_nervous | 1.33943154 |
| 66 | MP0002736_abnormal_nociception_after | 1.33301646 |
| 67 | MP0009745_abnormal_behavioral_response | 1.32090092 |
| 68 | MP0008872_abnormal_physiological_respon | 1.30783031 |
| 69 | MP0000049_abnormal_middle_ear | 1.30049020 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 1.29409423 |
| 71 | MP0004885_abnormal_endolymph | 1.28770811 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.26393160 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 1.25787019 |
| 74 | MP0000598_abnormal_liver_morphology | 1.23383934 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.22344912 |
| 76 | MP0003011_delayed_dark_adaptation | 1.21809474 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 1.21557006 |
| 78 | MP0002452_abnormal_antigen_presenting | 1.20220438 |
| 79 | MP0009697_abnormal_copulation | 1.18110555 |
| 80 | MP0005310_abnormal_salivary_gland | 1.17345995 |
| 81 | MP0005023_abnormal_wound_healing | 1.17131489 |
| 82 | MP0009643_abnormal_urine_homeostasis | 1.14699574 |
| 83 | MP0009046_muscle_twitch | 1.10971509 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 1.10308121 |
| 85 | MP0001873_stomach_inflammation | 1.10021337 |
| 86 | MP0003303_peritoneal_inflammation | 1.10005185 |
| 87 | MP0005670_abnormal_white_adipose | 1.09346665 |
| 88 | MP0003436_decreased_susceptibility_to | 1.08277620 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 1.08100813 |
| 90 | MP0002405_respiratory_system_inflammati | 1.03958245 |
| 91 | MP0001440_abnormal_grooming_behavior | 1.03693821 |
| 92 | MP0000026_abnormal_inner_ear | 1.02943353 |
| 93 | MP0009053_abnormal_anal_canal | 1.02763577 |
| 94 | MP0001502_abnormal_circadian_rhythm | 1.02747904 |
| 95 | MP0003329_amyloid_beta_deposits | 1.01715821 |
| 96 | MP0003119_abnormal_digestive_system | 1.01345173 |
| 97 | MP0009763_increased_sensitivity_to | 1.00432664 |
| 98 | MP0001764_abnormal_homeostasis | 0.99642805 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.99488901 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.99300675 |
| 101 | MP0006276_abnormal_autonomic_nervous | 0.96094561 |
| 102 | MP0005451_abnormal_body_composition | 0.95963825 |
| 103 | MP0001542_abnormal_bone_strength | 0.94605885 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.94470788 |
| 105 | MP0002102_abnormal_ear_morphology | 0.94338952 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.93317763 |
| 107 | MP0005025_abnormal_response_to | 0.93166168 |
| 108 | MP0002420_abnormal_adaptive_immunity | 0.93066969 |
| 109 | MP0001819_abnormal_immune_cell | 0.92307359 |
| 110 | MP0008789_abnormal_olfactory_epithelium | 0.91838437 |
| 111 | MP0009764_decreased_sensitivity_to | 0.90782137 |
| 112 | MP0003938_abnormal_ear_development | 0.90359569 |
| 113 | MP0000343_altered_response_to | 0.90196956 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.89395288 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.88241020 |
| 116 | MP0005195_abnormal_posterior_eye | 0.87980701 |
| 117 | MP0001243_abnormal_dermal_layer | 0.87822311 |
| 118 | MP0005275_abnormal_skin_tensile | 0.86586601 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.83927247 |
| 120 | MP0003279_aneurysm | 0.83224068 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.78065692 |
| 122 | MP0005248_abnormal_Harderian_gland | 0.78029294 |
| 123 | MP0002254_reproductive_system_inflammat | 0.77803718 |
| 124 | MP0002752_abnormal_somatic_nervous | 0.77547294 |
| 125 | MP0001970_abnormal_pain_threshold | 0.77475970 |
| 126 | MP0002168_other_aberrant_phenotype | 0.77362643 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.77211223 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.77195968 |
| 129 | MP0002064_seizures | 0.76678175 |
| 130 | MP0002928_abnormal_bile_duct | 0.75895888 |
| 131 | MP0004782_abnormal_surfactant_physiolog | 0.75146297 |
| 132 | MP0001944_abnormal_pancreas_morphology | 0.75074802 |
| 133 | MP0009642_abnormal_blood_homeostasis | 0.74325751 |
| 134 | MP0002184_abnormal_innervation | 0.73534186 |
| 135 | MP0001501_abnormal_sleep_pattern | 0.71714945 |
| 136 | MP0010155_abnormal_intestine_physiology | 0.71051463 |
| 137 | MP0006082_CNS_inflammation | 0.70929097 |
| 138 | MP0008469_abnormal_protein_level | 0.70591583 |
| 139 | MP0001881_abnormal_mammary_gland | 0.70507452 |
| 140 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70316616 |
| 141 | MP0002557_abnormal_social/conspecific_i | 0.69724552 |
| 142 | MP0000383_abnormal_hair_follicle | 0.69551278 |
| 143 | MP0005647_abnormal_sex_gland | 0.68769102 |
| 144 | MP0009384_cardiac_valve_regurgitation | 0.68646602 |
| 145 | MP0004272_abnormal_basement_membrane | 0.68387824 |
| 146 | MP0000955_abnormal_spinal_cord | 0.66851985 |
| 147 | MP0003566_abnormal_cell_adhesion | 0.66284071 |
| 148 | MP0002295_abnormal_pulmonary_circulatio | 0.65387717 |
| 149 | MP0002060_abnormal_skin_morphology | 0.65345387 |
| 150 | MP0001853_heart_inflammation | 0.65328575 |
| 151 | MP0005448_abnormal_energy_balance | 0.64758045 |
| 152 | MP0009765_abnormal_xenobiotic_induced | 0.63534696 |
| 153 | MP0005334_abnormal_fat_pad | 0.63366492 |
| 154 | MP0003186_abnormal_redox_activity | 0.61171917 |
| 155 | MP0005408_hypopigmentation | 0.61031917 |
| 156 | MP0005187_abnormal_penis_morphology | 0.60437329 |
| 157 | MP0001661_extended_life_span | 0.60291114 |
| 158 | MP0000249_abnormal_blood_vessel | 0.60258564 |
| 159 | MP0001533_abnormal_skeleton_physiology | 0.59657327 |
| 160 | MP0002971_abnormal_brown_adipose | 0.58292110 |
| 161 | MP0005376_homeostasis/metabolism_phenot | 0.57382765 |
| 162 | MP0003091_abnormal_cell_migration | 0.56003246 |
| 163 | MP0005636_abnormal_mineral_homeostasis | 0.55784445 |
| 164 | MP0005395_other_phenotype | 0.55705498 |
| 165 | MP0002090_abnormal_vision | 0.55213995 |
| 166 | MP0002896_abnormal_bone_mineralization | 0.54270457 |
| 167 | MP0003656_abnormal_erythrocyte_physiolo | 0.52817558 |
| 168 | MP0002089_abnormal_postnatal_growth/wei | 0.51266920 |
| 169 | MP0004130_abnormal_muscle_cell | 0.48919258 |
| 170 | MP0008961_abnormal_basal_metabolism | 0.48305125 |
| 171 | MP0004947_skin_inflammation | 0.47643580 |
| 172 | MP0002877_abnormal_melanocyte_morpholog | 0.47187989 |
| 173 | MP0000013_abnormal_adipose_tissue | 0.46237396 |
| 174 | MP0001756_abnormal_urination | 0.46208695 |
| 175 | MP0005164_abnormal_response_to | 0.46099397 |
| 176 | MP0005257_abnormal_intraocular_pressure | 0.45907211 |
| 177 | MP0003075_altered_response_to | 0.44968433 |
| 178 | MP0008873_increased_physiological_sensi | 0.44919803 |
| 179 | MP0003453_abnormal_keratinocyte_physiol | 0.44710609 |
| 180 | MP0000639_abnormal_adrenal_gland | 0.43364554 |
| 181 | MP0005464_abnormal_platelet_physiology | 0.43253189 |
| 182 | MP0003959_abnormal_lean_body | 0.42741266 |
| 183 | MP0005666_abnormal_adipose_tissue | 0.41327103 |
| 184 | MP0000685_abnormal_immune_system | 0.40502326 |
| 185 | MP0001958_emphysema | 0.39483802 |
| 186 | MP0009672_abnormal_birth_weight | 0.39357270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.60628556 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.96603326 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.20798899 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 6.14698190 |
| 5 | Xanthomatosis (HP:0000991) | 6.07850141 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.89702271 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.68739100 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.99147776 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.54860094 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54736262 |
| 11 | Joint hemorrhage (HP:0005261) | 4.32081787 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 4.15508739 |
| 13 | Epidermoid cyst (HP:0200040) | 4.05005138 |
| 14 | Hypoglycemic coma (HP:0001325) | 4.04252132 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.03470745 |
| 16 | Complement deficiency (HP:0004431) | 4.00010209 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 3.97432884 |
| 18 | Ketosis (HP:0001946) | 3.80621692 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78355564 |
| 20 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.76626744 |
| 21 | Short 1st metacarpal (HP:0010034) | 3.76626744 |
| 22 | Hyperammonemia (HP:0001987) | 3.73381249 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.60958476 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.59533176 |
| 25 | Myocardial infarction (HP:0001658) | 3.55163999 |
| 26 | Short hallux (HP:0010109) | 3.54835881 |
| 27 | Congenital, generalized hypertrichosis (HP:0004540) | 3.50357685 |
| 28 | Stomatitis (HP:0010280) | 3.36768279 |
| 29 | Pendular nystagmus (HP:0012043) | 3.36239667 |
| 30 | Stenosis of the external auditory canal (HP:0000402) | 3.34517833 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.34100434 |
| 32 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.32012842 |
| 33 | Abnormality of the 1st metacarpal (HP:0010009) | 3.26445363 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.25170069 |
| 35 | Fat malabsorption (HP:0002630) | 3.22906232 |
| 36 | Hypoglycemic seizures (HP:0002173) | 3.20643619 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.14369217 |
| 38 | Hyperglycinemia (HP:0002154) | 3.13708013 |
| 39 | Abnormality of complement system (HP:0005339) | 3.12762572 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.06273912 |
| 41 | Peritonitis (HP:0002586) | 3.05178781 |
| 42 | Anomalous pulmonary venous return (HP:0010772) | 3.05061773 |
| 43 | Acute necrotizing encephalopathy (HP:0006965) | 3.03301313 |
| 44 | Mitral stenosis (HP:0001718) | 3.01684627 |
| 45 | Esophageal varix (HP:0002040) | 3.00848061 |
| 46 | Skin nodule (HP:0200036) | 3.00322954 |
| 47 | Fused cervical vertebrae (HP:0002949) | 3.00165197 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.99346014 |
| 49 | Congenital stationary night blindness (HP:0007642) | 2.99256075 |
| 50 | Protrusio acetabuli (HP:0003179) | 2.92342181 |
| 51 | Hyperbilirubinemia (HP:0002904) | 2.83963271 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.82287392 |
| 53 | Abnormality of the pulmonary veins (HP:0011718) | 2.79422657 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76787265 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.76787265 |
| 56 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.76063247 |
| 57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75151271 |
| 58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.72874223 |
| 59 | Ketoacidosis (HP:0001993) | 2.71719968 |
| 60 | Menorrhagia (HP:0000132) | 2.69882600 |
| 61 | Absent thumb (HP:0009777) | 2.69231625 |
| 62 | Spontaneous abortion (HP:0005268) | 2.68080888 |
| 63 | Vascular calcification (HP:0004934) | 2.65736276 |
| 64 | Rib fusion (HP:0000902) | 2.65641564 |
| 65 | IgG deficiency (HP:0004315) | 2.65097068 |
| 66 | Mitochondrial inheritance (HP:0001427) | 2.64953592 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.64590872 |
| 68 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.64234789 |
| 69 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.63322686 |
| 70 | Progressive macrocephaly (HP:0004481) | 2.62284554 |
| 71 | Pancreatic cysts (HP:0001737) | 2.61065852 |
| 72 | Spastic diplegia (HP:0001264) | 2.56401641 |
| 73 | Hyperglycinuria (HP:0003108) | 2.55600560 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 2.55542299 |
| 75 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.53678389 |
| 76 | Abnormality of the renal collecting system (HP:0004742) | 2.51386179 |
| 77 | Abnormal number of erythroid precursors (HP:0012131) | 2.50234493 |
| 78 | Late onset (HP:0003584) | 2.49472286 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.47224704 |
| 80 | Adactyly (HP:0009776) | 2.46236799 |
| 81 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.45975441 |
| 82 | Gout (HP:0001997) | 2.42466497 |
| 83 | Delayed CNS myelination (HP:0002188) | 2.39792636 |
| 84 | Vertebral fusion (HP:0002948) | 2.38156646 |
| 85 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.36533415 |
| 86 | Reticulocytopenia (HP:0001896) | 2.35415391 |
| 87 | Short phalanx of the thumb (HP:0009660) | 2.34996814 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.34286678 |
| 89 | Methylmalonic acidemia (HP:0002912) | 2.33689887 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.33177442 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.32856143 |
| 92 | Cholecystitis (HP:0001082) | 2.32856143 |
| 93 | Back pain (HP:0003418) | 2.32164445 |
| 94 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.31921556 |
| 95 | Pancreatic fibrosis (HP:0100732) | 2.31568648 |
| 96 | Ectopic kidney (HP:0000086) | 2.30779423 |
| 97 | Premature rupture of membranes (HP:0001788) | 2.30568712 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 2.28525098 |
| 99 | Increased CSF lactate (HP:0002490) | 2.27716346 |
| 100 | Hyperglycemia (HP:0003074) | 2.27342888 |
| 101 | Acute encephalopathy (HP:0006846) | 2.26429520 |
| 102 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.25807661 |
| 103 | True hermaphroditism (HP:0010459) | 2.25219419 |
| 104 | Cholelithiasis (HP:0001081) | 2.24663204 |
| 105 | Increased mean platelet volume (HP:0011877) | 2.23458440 |
| 106 | Nephronophthisis (HP:0000090) | 2.23262540 |
| 107 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.23040119 |
| 108 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.21928124 |
| 109 | 3-Methylglutaconic aciduria (HP:0003535) | 2.21835179 |
| 110 | Abnormality of the nasal septum (HP:0000419) | 2.21093496 |
| 111 | Asplenia (HP:0001746) | 2.20082369 |
| 112 | Steatorrhea (HP:0002570) | 2.19165610 |
| 113 | Adrenal hypoplasia (HP:0000835) | 2.18243615 |
| 114 | Hypoplasia of the uterus (HP:0000013) | 2.17709012 |
| 115 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.17205132 |
| 116 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.16743220 |
| 117 | Malnutrition (HP:0004395) | 2.15942000 |
| 118 | Symptomatic seizures (HP:0011145) | 2.14771296 |
| 119 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.13545714 |
| 120 | Molar tooth sign on MRI (HP:0002419) | 2.11386911 |
| 121 | Abnormality of midbrain morphology (HP:0002418) | 2.11386911 |
| 122 | Hypochromic microcytic anemia (HP:0004840) | 2.10589351 |
| 123 | Methylmalonic aciduria (HP:0012120) | 2.09201845 |
| 124 | Irritability (HP:0000737) | 2.09146241 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.06742444 |
| 126 | Abnormal cartilage morphology (HP:0002763) | 2.05582578 |
| 127 | Abnormality of proline metabolism (HP:0010907) | 2.04449216 |
| 128 | Hydroxyprolinuria (HP:0003080) | 2.04449216 |
| 129 | Increased hepatocellular lipid droplets (HP:0006565) | 2.03612376 |
| 130 | Ectopia lentis (HP:0001083) | 2.03524672 |
| 131 | Hemorrhage of the eye (HP:0011885) | 2.03254495 |
| 132 | Carpal bone hypoplasia (HP:0001498) | 2.01914014 |
| 133 | Polycythemia (HP:0001901) | 2.01892343 |
| 134 | Metabolic acidosis (HP:0001942) | 2.01299541 |
| 135 | Chorioretinal atrophy (HP:0000533) | 2.00765767 |
| 136 | Thyroiditis (HP:0100646) | 2.00678745 |
| 137 | Neonatal onset (HP:0003623) | 2.00497260 |
| 138 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00436970 |
| 139 | Abnormality of the Achilles tendon (HP:0005109) | 2.00366249 |
| 140 | Glomerulonephritis (HP:0000099) | 1.98081759 |
| 141 | Optic disc pallor (HP:0000543) | 1.97473988 |
| 142 | Hypoplasia of the ulna (HP:0003022) | 1.96902931 |
| 143 | Gingival bleeding (HP:0000225) | 1.95648646 |
| 144 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.94010123 |
| 145 | Porencephaly (HP:0002132) | 1.93144083 |
| 146 | Horseshoe kidney (HP:0000085) | 1.92167486 |
| 147 | Synostosis of carpal bones (HP:0005048) | 1.92003465 |
| 148 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90448237 |
| 149 | Abnormal platelet volume (HP:0011876) | 1.89688547 |
| 150 | Thrombophlebitis (HP:0004418) | 1.89159992 |
| 151 | Increased IgM level (HP:0003496) | 1.85497789 |
| 152 | Abnormality of the renal medulla (HP:0100957) | 1.84675746 |
| 153 | Amyloidosis (HP:0011034) | 1.84661358 |
| 154 | Maternal diabetes (HP:0009800) | 1.83731495 |
| 155 | Abnormality of DNA repair (HP:0003254) | 1.83622879 |
| 156 | Reticulocytosis (HP:0001923) | 1.83281681 |
| 157 | Abnormality of the gallbladder (HP:0005264) | 1.82268538 |
| 158 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.81596529 |
| 159 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.81575415 |
| 160 | Increased corneal curvature (HP:0100692) | 1.81574351 |
| 161 | Keratoconus (HP:0000563) | 1.81574351 |
| 162 | Opisthotonus (HP:0002179) | 1.81454555 |
| 163 | Abnormal pancreas size (HP:0012094) | 1.80569008 |
| 164 | Severe combined immunodeficiency (HP:0004430) | 1.80371802 |
| 165 | Renal Fanconi syndrome (HP:0001994) | 1.79535824 |
| 166 | Alveolar cell carcinoma (HP:0006519) | 1.78912748 |
| 167 | Enlarged kidneys (HP:0000105) | 1.78754021 |
| 168 | Joint swelling (HP:0001386) | 1.78222020 |
| 169 | Medial flaring of the eyebrow (HP:0010747) | 1.77748850 |
| 170 | Pancreatitis (HP:0001733) | 1.76618812 |
| 171 | Optic neuritis (HP:0100653) | 1.76486081 |
| 172 | Retrobulbar optic neuritis (HP:0100654) | 1.76486081 |
| 173 | Prostate neoplasm (HP:0100787) | 1.76253196 |
| 174 | Acanthocytosis (HP:0001927) | 1.76229183 |
| 175 | Infantile muscular hypotonia (HP:0008947) | 1.75788330 |
| 176 | Abnormality of iron homeostasis (HP:0011031) | 1.75494974 |
| 177 | Stroke (HP:0001297) | 1.75178481 |
| 178 | Tachypnea (HP:0002789) | 1.75027978 |
| 179 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74322583 |
| 180 | Absent phalangeal crease (HP:0006109) | 1.74316242 |
| 181 | Protuberant abdomen (HP:0001538) | 1.74255416 |
| 182 | Progressive cerebellar ataxia (HP:0002073) | 1.73227096 |
| 183 | Turricephaly (HP:0000262) | 1.72422450 |
| 184 | Acute hepatic failure (HP:0006554) | 1.71732892 |
| 185 | Morphological abnormality of the middle ear (HP:0008609) | 1.71363247 |
| 186 | Duplicated collecting system (HP:0000081) | 1.70878365 |
| 187 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69539872 |
| 188 | Brushfield spots (HP:0001088) | 1.69212177 |
| 189 | Concave nail (HP:0001598) | 1.66583875 |
| 190 | Abnormality of eosinophils (HP:0001879) | 1.66526237 |
| 191 | Hemiplegia (HP:0002301) | 1.65270417 |
| 192 | Synostosis involving the elbow (HP:0003938) | 1.64864210 |
| 193 | Humeroradial synostosis (HP:0003041) | 1.64864210 |
| 194 | Stomach cancer (HP:0012126) | 1.64366865 |
| 195 | Furrowed tongue (HP:0000221) | 1.63341781 |
| 196 | Erythroderma (HP:0001019) | 1.62720880 |
| 197 | Oral leukoplakia (HP:0002745) | 1.61779980 |
| 198 | Agitation (HP:0000713) | 1.60977963 |
| 199 | Severe muscular hypotonia (HP:0006829) | 1.60846118 |
| 200 | Cerebral edema (HP:0002181) | 1.60706027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 4.40290621 |
| 2 | ERN1 | 4.32952602 |
| 3 | FGFR4 | 3.97413033 |
| 4 | GRK1 | 3.69190355 |
| 5 | TRIB3 | 3.59427915 |
| 6 | BCKDK | 3.41155639 |
| 7 | SIK1 | 3.33969335 |
| 8 | PKN2 | 3.09591768 |
| 9 | EPHA2 | 3.01129448 |
| 10 | TLK1 | 2.93400685 |
| 11 | INSRR | 2.64544625 |
| 12 | ZAK | 2.44377699 |
| 13 | GRK7 | 2.23814920 |
| 14 | PTK6 | 2.07756438 |
| 15 | TAF1 | 1.98281386 |
| 16 | NME2 | 1.92359890 |
| 17 | EPHA3 | 1.87474594 |
| 18 | PDGFRA | 1.81762035 |
| 19 | LATS1 | 1.80243407 |
| 20 | PTK2 | 1.78405415 |
| 21 | MAP4K2 | 1.77793002 |
| 22 | FLT3 | 1.76090652 |
| 23 | ERBB4 | 1.72643233 |
| 24 | RIPK1 | 1.71297959 |
| 25 | NUAK1 | 1.69190106 |
| 26 | IRAK3 | 1.69005026 |
| 27 | MAP3K3 | 1.67464819 |
| 28 | BLK | 1.66787920 |
| 29 | KDR | 1.65781828 |
| 30 | STK16 | 1.64869934 |
| 31 | BMPR1B | 1.61097439 |
| 32 | VRK2 | 1.58113487 |
| 33 | STK24 | 1.57976430 |
| 34 | IKBKE | 1.50970356 |
| 35 | FGFR3 | 1.47164033 |
| 36 | FGFR1 | 1.42965329 |
| 37 | PIK3CG | 1.42756569 |
| 38 | MAP3K7 | 1.41071263 |
| 39 | ITK | 1.39205585 |
| 40 | EPHB1 | 1.38724529 |
| 41 | PAK2 | 1.38713204 |
| 42 | TAOK3 | 1.36756667 |
| 43 | TAOK2 | 1.36047110 |
| 44 | PLK2 | 1.33543353 |
| 45 | DYRK3 | 1.32189256 |
| 46 | PAK3 | 1.28366196 |
| 47 | MAP3K11 | 1.26822119 |
| 48 | MAP2K3 | 1.25585566 |
| 49 | ZAP70 | 1.23751991 |
| 50 | JAK3 | 1.22852595 |
| 51 | TAOK1 | 1.21034864 |
| 52 | VRK1 | 1.19743491 |
| 53 | DYRK1B | 1.15229807 |
| 54 | MAP3K14 | 1.15031581 |
| 55 | MAP4K1 | 1.14058409 |
| 56 | WNK3 | 1.13431891 |
| 57 | TNIK | 1.12909123 |
| 58 | PDK2 | 1.12641467 |
| 59 | MAP2K7 | 1.12168249 |
| 60 | DYRK2 | 1.10287221 |
| 61 | NME1 | 1.09670664 |
| 62 | CDK9 | 1.09355318 |
| 63 | MST1R | 1.08414474 |
| 64 | TTN | 1.06024884 |
| 65 | MAP3K10 | 1.05927017 |
| 66 | FER | 1.00616736 |
| 67 | PIM2 | 1.00570790 |
| 68 | PASK | 1.00169382 |
| 69 | TYK2 | 0.98879270 |
| 70 | PRKCG | 0.98344489 |
| 71 | MKNK2 | 0.96120075 |
| 72 | TBK1 | 0.96070063 |
| 73 | MTOR | 0.95884484 |
| 74 | PINK1 | 0.93833792 |
| 75 | MET | 0.92285470 |
| 76 | CHUK | 0.91425983 |
| 77 | DDR2 | 0.91235160 |
| 78 | JAK1 | 0.89544372 |
| 79 | MAP3K9 | 0.88533703 |
| 80 | BMX | 0.88326188 |
| 81 | PKN1 | 0.85840325 |
| 82 | SYK | 0.85440741 |
| 83 | GSK3A | 0.85107765 |
| 84 | RPS6KA5 | 0.84694861 |
| 85 | IRAK4 | 0.84058134 |
| 86 | MAP3K4 | 0.82954323 |
| 87 | MAPK15 | 0.82866364 |
| 88 | MUSK | 0.82502935 |
| 89 | GRK5 | 0.82296081 |
| 90 | TXK | 0.78534430 |
| 91 | JAK2 | 0.77915549 |
| 92 | ADRBK1 | 0.77205732 |
| 93 | LATS2 | 0.77081347 |
| 94 | PIM1 | 0.77028764 |
| 95 | NEK9 | 0.76126429 |
| 96 | TEC | 0.74776654 |
| 97 | PRKCH | 0.74071690 |
| 98 | ACVR1B | 0.73335236 |
| 99 | KIT | 0.72459743 |
| 100 | FRK | 0.72004642 |
| 101 | RPS6KA4 | 0.70635696 |
| 102 | RPS6KA6 | 0.70431518 |
| 103 | MAP2K4 | 0.70014251 |
| 104 | LRRK2 | 0.69934544 |
| 105 | LCK | 0.69426937 |
| 106 | ABL2 | 0.68557831 |
| 107 | NTRK2 | 0.66447500 |
| 108 | EEF2K | 0.66208175 |
| 109 | CDC7 | 0.65839863 |
| 110 | MST4 | 0.65485746 |
| 111 | CDK6 | 0.65251356 |
| 112 | BMPR2 | 0.65090219 |
| 113 | FGFR2 | 0.64743729 |
| 114 | MAP2K1 | 0.64588312 |
| 115 | TIE1 | 0.64430305 |
| 116 | MATK | 0.64066861 |
| 117 | NTRK1 | 0.63119032 |
| 118 | EPHB2 | 0.63036551 |
| 119 | PRKCQ | 0.62615247 |
| 120 | * LYN | 0.61881506 |
| 121 | CSNK1G2 | 0.61654141 |
| 122 | TGFBR2 | 0.61554952 |
| 123 | MAPK11 | 0.59328994 |
| 124 | IGF1R | 0.59013969 |
| 125 | CSNK1A1 | 0.58733658 |
| 126 | RET | 0.58428304 |
| 127 | DAPK3 | 0.56563509 |
| 128 | MAP3K1 | 0.56378046 |
| 129 | PDGFRB | 0.55370812 |
| 130 | HIPK2 | 0.54930648 |
| 131 | PRKCE | 0.54020118 |
| 132 | PRKACA | 0.53091157 |
| 133 | MKNK1 | 0.52821439 |
| 134 | CSNK1G3 | 0.52257883 |
| 135 | MAPKAPK5 | 0.49723557 |
| 136 | CAMK2A | 0.49621229 |
| 137 | PRKCZ | 0.49062019 |
| 138 | CSNK1G1 | 0.47921174 |
| 139 | PAK6 | 0.47649671 |
| 140 | TGFBR1 | 0.46856161 |
| 141 | BTK | 0.46579463 |
| 142 | ICK | 0.45581337 |
| 143 | CAMKK2 | 0.45342635 |
| 144 | RPS6KC1 | 0.45259754 |
| 145 | RPS6KL1 | 0.45259754 |
| 146 | PRKAA2 | 0.44517294 |
| 147 | PRKACG | 0.44127265 |
| 148 | * INSR | 0.43720444 |
| 149 | DAPK2 | 0.42982787 |
| 150 | AURKA | 0.42786300 |
| 151 | RIPK4 | 0.42602615 |
| 152 | CAMK1D | 0.42420087 |
| 153 | TESK1 | 0.40558365 |
| 154 | TESK2 | 0.40300186 |
| 155 | CSNK2A1 | 0.40155741 |
| 156 | ERBB2 | 0.40106046 |
| 157 | MAPK7 | 0.40084484 |
| 158 | PTK2B | 0.39985157 |
| 159 | MOS | 0.39934779 |
| 160 | STK38L | 0.39696897 |
| 161 | MAP3K5 | 0.39433510 |
| 162 | SGK2 | 0.38653907 |
| 163 | PRKCD | 0.38090289 |
| 164 | PRKG2 | 0.35990108 |
| 165 | MAPK13 | 0.35577498 |
| 166 | CASK | 0.35012779 |
| 167 | CAMK1G | 0.34997214 |
| 168 | PRKCA | 0.34960419 |
| 169 | IKBKB | 0.34600622 |
| 170 | MAPK4 | 0.34579972 |
| 171 | * CSK | 0.34024988 |
| 172 | IRAK1 | 0.33454751 |
| 173 | PRKCI | 0.33448834 |
| 174 | GRK6 | 0.32886005 |
| 175 | HCK | 0.31985055 |
| 176 | STK10 | 0.31780298 |
| 177 | PAK4 | 0.31337485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38307690 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.75236922 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.61570053 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.54874175 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.25199656 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11312649 |
| 7 | Asthma_Homo sapiens_hsa05310 | 3.03468044 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.88440510 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.88391531 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85653569 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.82091922 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.65791748 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58523637 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.58180481 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53146480 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 2.45488604 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38957986 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36720705 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33956043 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.29595193 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.28162717 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.22359414 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19412460 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.13475868 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11277124 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 2.11097504 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10054026 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.01467060 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00489689 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94973009 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93321932 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.91385657 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82509052 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80405706 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.78192302 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77305974 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75311811 |
| 38 | Protein export_Homo sapiens_hsa03060 | 1.74203862 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.73938760 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71913076 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.70685862 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.70626192 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69324751 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69203626 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.68376034 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67195106 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66216768 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.64580203 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.62559194 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62471856 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59636769 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57179552 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47428061 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47221648 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46002992 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43412282 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41753937 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.31109717 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29509902 |
| 60 | Proteasome_Homo sapiens_hsa03050 | 1.27379218 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27002043 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26477470 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26030246 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25974235 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25688018 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25271366 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22261016 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 1.22247966 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 1.20769891 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20531253 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16717340 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 1.16541279 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16241970 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15555492 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10012531 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09077541 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08050145 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07183756 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05629838 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04541406 |
| 81 | Nicotine addiction_Homo sapiens_hsa05033 | 1.00773572 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.98431716 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98138724 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97122402 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96296631 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95691788 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.92694821 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.92186049 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.90160547 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89364993 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88946773 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85907938 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.84948263 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84516867 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84466043 |
| 96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.77926924 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77321999 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75605022 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74324462 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73125927 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71521769 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64681364 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.63969599 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63680325 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63584025 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.56018556 |
| 107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55842744 |
| 108 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52413832 |
| 109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52229902 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51038002 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50935869 |
| 112 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49823018 |
| 113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48791497 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48188758 |
| 115 | Pertussis_Homo sapiens_hsa05133 | 0.47633586 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47575928 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.47322812 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45970597 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.45775334 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45048386 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.44178692 |
| 122 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44115740 |
| 123 | GABAergic synapse_Homo sapiens_hsa04727 | 0.44011933 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42554424 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.42214204 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.42174083 |
| 127 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41011311 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40229089 |
| 129 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40143546 |
| 130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39795798 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39753084 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39126089 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | 0.37798546 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37589925 |
| 135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36690208 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34552675 |
| 137 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33233307 |
| 138 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32249792 |
| 139 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.32108975 |
| 140 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31551652 |
| 141 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31186894 |
| 142 | Influenza A_Homo sapiens_hsa05164 | 0.30631196 |
| 143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30564887 |
| 144 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29593098 |
| 145 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28651427 |
| 146 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.26157489 |
| 147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25854850 |
| 148 | Tuberculosis_Homo sapiens_hsa05152 | 0.24778703 |
| 149 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.20453166 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19765834 |
| 151 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18243055 |
| 152 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17988138 |
| 153 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16768608 |
| 154 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.16405169 |
| 155 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15014196 |
| 156 | Amoebiasis_Homo sapiens_hsa05146 | 0.13299839 |
| 157 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12593537 |
| 158 | Malaria_Homo sapiens_hsa05144 | 0.11591978 |
| 159 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.11325876 |
| 160 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.10551890 |
| 161 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08612157 |
| 162 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08347525 |
| 163 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.04962183 |
| 164 | Focal adhesion_Homo sapiens_hsa04510 | 0.03385209 |
| 165 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.01865788 |
| 166 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0822473 |
| 167 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0729335 |
| 168 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0661414 |
| 169 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0588278 |
| 170 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0582852 |
| 171 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | -0.0578345 |
| 172 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0517897 |
| 173 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0496680 |
| 174 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | -0.0476650 |
| 175 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0166339 |

